Asia Pacific Pharmacogenomics Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)

No. of Pages: 170
Report Code: TIPRE00028847
Category: Life Sciences
Asia Pacific Pharmacogenomics Market
Free Sample Buy Now

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Asia Pacific Pharmacogenomics Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Pharmacogenomics Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Asia Pacific Pharmacogenomics Market Regional Analysis

6.2 Asia Pacific Pharmacogenomics Market Revenue 2019-2028 (US$ Million)
6.3 Asia Pacific Pharmacogenomics Market Forecast Analysis

7. Asia Pacific Pharmacogenomics Market Analysis – by Technology

7.1 PCR
  • 7.1.1 Overview
  • 7.1.2 PCR: Asia Pacific Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Sequencing
  • 7.2.1 Overview
  • 7.2.2 Sequencing: Asia Pacific Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Microarray
  • 7.3.1 Overview
  • 7.3.2 Microarray: Asia Pacific Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Gel Electrophoresis
  • 7.4.1 Overview
  • 7.4.2 Gel Electrophoresis: Asia Pacific Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.5 Mass Spectrometry
  • 7.5.1 Overview
  • 7.5.2 Mass Spectrometry: Asia Pacific Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Asia Pacific Pharmacogenomics Market Analysis – by Application

8.1 Drug Discovery
  • 8.1.1 Overview
  • 8.1.2 Drug Discovery: Asia Pacific Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Oncology
  • 8.2.1 Overview
  • 8.2.2 Oncology: Asia Pacific Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Neurology and Psychiatry
  • 8.3.1 Overview
  • 8.3.2 Neurology and Psychiatry: Asia Pacific Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 Pain Management
  • 8.4.1 Overview
  • 8.4.2 Pain Management: Asia Pacific Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.5 Cardiovascular Diseases
  • 8.5.1 Overview
  • 8.5.2 Cardiovascular Diseases: Asia Pacific Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Asia Pacific Pharmacogenomics Market Analysis – by End User

9.1 Hospitals and Clinics
  • 9.1.1 Overview
  • 9.1.2 Hospitals and Clinics: Asia Pacific Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Biopharmaceutical Companies
  • 9.2.1 Overview
  • 9.2.2 Biopharmaceutical Companies: Asia Pacific Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 CROs and CDMOs
  • 9.3.1 Overview
  • 9.3.2 CROs and CDMOs: Asia Pacific Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. Asia Pacific Pharmacogenomics Market – Asia-Pacific Analysis

10.1 Overview

10.2 Asia-Pacific
  • 10.2.1 Asia Pacific Pharmacogenomics Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.2.1.1 Asia Pacific Pharmacogenomics Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 China: Asia Pacific Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.1.1 China: Asia Pacific Pharmacogenomics Market Breakdown, by Technology
    • 10.2.1.1.2 China: Asia Pacific Pharmacogenomics Market Breakdown, by Application
    • 10.2.1.1.3 China: Asia Pacific Pharmacogenomics Market Breakdown, by End User
  • 10.2.1.2 India: Asia Pacific Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.2.1 India: Asia Pacific Pharmacogenomics Market Breakdown, by Technology
    • 10.2.1.2.2 India: Asia Pacific Pharmacogenomics Market Breakdown, by Application
    • 10.2.1.2.3 India: Asia Pacific Pharmacogenomics Market Breakdown, by End User
  • 10.2.1.3 Japan: Asia Pacific Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.3.1 Japan: Asia Pacific Pharmacogenomics Market Breakdown, by Technology
    • 10.2.1.3.2 Japan: Asia Pacific Pharmacogenomics Market Breakdown, by Application
    • 10.2.1.3.3 Japan: Asia Pacific Pharmacogenomics Market Breakdown, by End User
  • 10.2.1.4 Australia: Asia Pacific Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.4.1 Australia: Asia Pacific Pharmacogenomics Market Breakdown, by Technology
    • 10.2.1.4.2 Australia: Asia Pacific Pharmacogenomics Market Breakdown, by Application
    • 10.2.1.4.3 Australia: Asia Pacific Pharmacogenomics Market Breakdown, by End User
  • 10.2.1.5 Rest of Asia-Pacific : Asia Pacific Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Pharmacogenomics Market Breakdown, by Technology
    • 10.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Pharmacogenomics Market Breakdown, by Application
    • 10.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Pharmacogenomics Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Abbott
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 F. HOFFMANN-LA ROCHE LTD.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Oxford Nanopore Technologies
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 THERMO FISHER SCIENTIFIC INC.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Illumina, Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 QIAGEN
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Agilent Technologies, Inc.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Myriad Genetics, Inc.
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Asia Pacific Pharmacogenomics Market

  • Abbott
  • F. HOFFMANN-LA ROCHE LTD.
  • Oxford Nanopore Technologies
  • THERMO FISHER SCIENTIFIC INC.
  • Illumina, Inc.
  • QIAGEN
  • Agilent Technologies, Inc.
  • Myriad Genetics, Inc.

    • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)